Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
DOI:
https://doi.org/10.22270/ajprd.v9i4.980Keywords:
Solubility, Bioavailability, dissolution enhancement, crystal engineeringAbstract
Solubility, the phenomenon of dissolution of solute in solvent to give a homogenous system, is one of the important parameters to achieve desired concentration of drug in systemic circulation for desired pharmacological response. Low aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic development. A success of formulation development depends on how efficiently it makes the drug available at the site of action. Poorly soluble and dissolution profile creates problem in pharmaceutical industry for development of dosage form. The ability to increase aqueous solubility can thus be a valuable aid to increasing efficiency and/or reducing side effects (Adverse drug reaction) for drugs. This is true for parenterally, topically and orally administered solutions. Biopharmaceutical classification system (BCS) highlights the dissolution as rate limiting step for oral absorption of BCS class II and class IVdrugs. BCS class II and class IV drugs have low solubility.Increasing dissolution directly correlated to bioavailability of drug at site of action or systemic circulation. In this article we discuss, concept of dissolution, factors affecting dissolution,different techniques used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction, crystal engineering, salt formation, solid dispersion, use of surfactant, complexation with hydrophilic excipients.
Downloads
References
2. Clugston M, & Fleming R. Advanced Chemistry. 1st ed. UK: Oxford Publishing, 2000. p 200-348.
3. Myrdal P. B, and Yalkowsky S. H, Solubilization of drugs in aqueous media, in Encyclopedia of Pharmaceutical Technology, 3rd ed. USA: Informa Health Care; 2007. p. 3311.
4. Amidon G. L, Lennern H, Shah V. P., & Crison J. R., Avtheoretical basis for a biopharmaceutic drug classification: thevcorrelation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, 1995; 12(3):414-420.
5. Ahmad Z., Maurya N., Mishra K., Khan I., Solubility enhancement of poorly water soluble drugs: a review, International Journal of Pharmacy and Technology 2011; 2(1):807-23.
6. Kumar A., Sahoo K., Padhee K., Singh P., Satapathy A., Pathak N., Review on solubility enhancement techniques for hydrophobic drugs, International journal of comprehensive pharmacy 2011; 3(3):1-7.
7. Kumar P., Singh C., Study on solubility enhancement methods for poorly water soluble drugs, American Journal of Pharmacological Sciences, 2013; 1(4): 67-73.
8. Vemula V., Lagishetty V., Lingala S., Solubility enhancement techniques, International Journal of Pharmaceutical Sciences Review and Research 2010; 5:1: 41-51.
9. Indian Pharmacopoeia, Controller of Publication, Govt. of India, Ministry of Health and Family Welfare, New Delhi, 2007.p. 143.
10. Reddy B., Karunakar A., Biopharmaceutics classification system: a regulatory approach, Dissolution Technologies 2011; 2(7):31-37.
11. Chaudhary A., Nagaich U., Gulati N., Sharma V., Khosa R., Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications A recent review, Journal of Advanced Pharmacy Education and Research 2012; 2(1):32-67.
12. Reddy N., Reddy A., Kavitha K., Kumar R., et al. Review on: better solubility enhancement of poorly water soluble drugs, International Journal of Inventions in Pharmaceutical Sciences 2013; 1(4): 267-73.
13. Shan N, & Zaworotko M. J, “The role of cocrystals in pharmaceutical science,” Drug Discovery Today, 2008; 13(910):440-4446.
14. Hickey M. B, Peterson M. L, Scoppettuolo L. A, “Performance comparison of a co-crystal of carbamazepine with marketed product,” European Journal of Pharmaceutics and Biopharmaceutics, 2007; 67(1):112-119.
15. Childs S. L, Chyall L. J,. Dunlap J. T, Smolenskaya V. N, Stahly B. C, & Stahly G. P. , “Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids,” Journal of the American Chemical Society, 2004; 126(41) :3335-13342.
16. Remenar J. F, Morissette S. L, Peterson M. L. et al., “Crystal engineering of novel cocrystals of a triazole drug with 1,4dicarboxylic acids,” Journal of the American Chemical Society, 2003; 125(28): 8456-8457.
17. Moribe K, Tozuka Y, & Yamamoto K,“Supercriticalcarbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation,” Advanced Drug Delivery Reviews, 2009: 60(3) : 328-338.
18. Pasquali I, Bettini, R & Giordano F., “Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals,” Advanced Drug Delivery Reviews, 2008; 60(3):399-410.
19. Paradkar. A, Maheshwari M, Kamble K, “Design and evaluation of celecoxib porous particles using melt sonocrystallization,” Pharmaceutical Research, 2006; 23(6):1395-1400
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).